Literature DB >> 869348

Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum.

A C Steere, S E Malawista, J A Hardin, S Ruddy, W Askenase, W A Andiman.   

Abstract

Thirty-two patients with the onset of erythema chronicum migrans, Lyme arthritis, or both in mid-1976 were studied prospectively. The skin lesion (24 patients) typically lasted about 3 weeks, beginning as a red macule or papule that expanded to form a large ring with central clearing. Associated symptoms ranged from none to malaise, fatigue, chills and fever, headache, stiff neck, backache, myalgias, nausea, vomiting, and sore throat. Three patients had been bitten by ticks at the site of the initial lesion 4 to 20 days before its onset. Nineteen patients suddenly developed a monoarticular or oligoarticular arthritis 4 days to 22 weeks (median, 4 weeks) after onset of the skin lesion; eight developed arthritis without a preceding skin lesion. Seven of these 27 experienced migratory joint pains. Arthritis attacks, most commonly in the knee, were typically short (median, 8 days) but sometimes persisted for months. Other manifestations included neurologic abnormalties, myocardial conduction abnormalities, serum cryoprecipitates, elevated serum IgM levels, and elevated erythrocyte sedimentation rates. The diagnostic marker is the skin lesion; without it, geographic clustering is the most important clue.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 869348     DOI: 10.7326/0003-4819-86-6-685

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  142 in total

1.  National survey of state epidemiologists to determine the status of Lyme disease surveillance.

Authors:  R L Vogt
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

2.  Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling.

Authors:  Bikash Sahay; Kathleen Bashant; Nicole L J Nelson; Rebeca L Patsey; Shiva Kumar Gadila; Rebecca Boohaker; Ashutosh Verma; Klemen Strle; Timothy J Sellati
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi.

Authors:  P A Rosa; D Hogan; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

4.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

Review 5.  How to diagnose and treat Lyme disease in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-07-15       Impact factor: 8.262

6.  Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.

Authors:  V Preac Mursic; E Patsouris; B Wilske; S Reinhardt; B Gross; P Mehraein
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

7.  Association of HLA-DR2 antigen with serum IgG antibodies against Borrelia burgdorferi in Bannwarth's syndrome.

Authors:  J H Wokke; P A van Doorn; A Brand; G M Schreuder; M Vermeulen
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

8.  Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease.

Authors:  L A Magnarelli; J M Meegan; J F Anderson; W A Chappell
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

9.  Comparison of Western blot and enzyme-linked immunosorbent assay for diagnosis of Lyme borreliosis.

Authors:  M Karlsson; I Möllegård; G Stiernstedt; B Wretlind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

10.  Complete heart block in a 9 year old girl caused by borreliosis.

Authors:  H P Gildein; S Günther; R Mocellin
Journal:  Br Heart J       Date:  1993-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.